In 2004, for the first time in human study, Nikolaidis L.A, et al. investigated the safety and efficacy of infusion GLP-1 for Acute Myocardial Infarction (AMI) with Left Ventricular (LV) disfunction. This evidence concerns the gene GCG and myocardial infarction.